{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:14:39Z","timestamp":1784747679377,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241025"],"award-info":[{"award-number":["82241025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300079"],"award-info":[{"award-number":["82300079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173817"],"award-info":[{"award-number":["82173817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.taap.2025.117657","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:17:38Z","timestamp":1764001058000},"page":"117657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis"],"prefix":"10.1016","volume":"507","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117657_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108778","article-title":"Cytoplasmic cleavage of IMPA1 3' UTR is necessary for maintaining axon integrity","volume":"34","author":"Andreassi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.taap.2025.117657_bb0010","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2025.117657_bb0015","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117657_bb0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","article-title":"Inositol trisphosphate and calcium signalling mechanisms","volume":"1793","author":"Berridge","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2025.117657_bb0025","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial\u2013hypoxia inducible factor-1alpha\u2013Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117657_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCULATIONAHA.109.848911","article-title":"Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt\/GSK3-beta\/NFAT axis","volume":"120","author":"Bonnet","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2025.117657_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173438","article-title":"Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension","volume":"887","author":"Braga","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2025.117657_bb0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.apsb.2024.12.040","article-title":"Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME \u201ctwo-hit\u201d in mice","volume":"15","author":"Chen","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2025.117657_bb0045","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1172\/JCI120847","article-title":"Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains","volume":"128","author":"Culley","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2025.117657_bb0050","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.taap.2025.117657_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/cjpp-2017-0533","article-title":"Time-dependent therapeutic roles of nitazoxanide on high-fat diet\/streptozotocin-induced diabetes in rats: effects on hepatic peroxisome proliferator-activated receptor-gamma receptors","volume":"96","author":"Elaidy","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2025.117657_bb0060","first-page":"4615","article-title":"Tilapia (Oreochromis mossambicus) brain cells respond to hyperosmotic challenge by inducing myo-inositol biosynthesis","volume":"216","author":"Gardell","year":"2013","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.taap.2025.117657_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41569-024-01064-4","article-title":"Mechanisms and treatment of pulmonary arterial hypertension","volume":"22","author":"Ghofrani","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.taap.2025.117657_bb0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12020-025-04387-5","article-title":"Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial","volume":"90","author":"Ghonaim","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.taap.2025.117657_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yjmcc.2016.01.009","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension","volume":"91","author":"Guo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2025.117657_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2022.05.038","article-title":"Clinical characteristics and transplant-free survival across the spectrum of pulmonary vascular disease","volume":"80","author":"Hemnes","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2025.117657_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41598-019-57200-5","article-title":"Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment","volume":"10","author":"Hernandez-Saavedra","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117657_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2025.117657_bb0095","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits ebola virus","volume":"19","author":"Jasenosky","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.taap.2025.117657_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s40265-024-02058-9","article-title":"Sotatercept: first approval","volume":"84","author":"Kang","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.taap.2025.117657_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2025.117657_bb0110","first-page":"297","article-title":"Vascular remodeling in pulmonary hypertension","volume":"3","author":"Larissa","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"10.1016\/j.taap.2025.117657_bb0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.118.11932","article-title":"Targeted delivery of sildenafil for inhibiting pulmonary vascular remodeling","volume":"73","author":"Li","year":"2019","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"key":"10.1016\/j.taap.2025.117657_bb0120","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.apsb.2021.09.009","article-title":"Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.taap.2025.117657_bb0125","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.apsb.2024.03.031","article-title":"The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharmaceut. Sin. B"},{"key":"10.1016\/j.taap.2025.117657_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116205","article-title":"The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice","volume":"224","author":"Liu","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.taap.2025.117657_bb0135","first-page":"993","volume":"47","author":"Lu","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.taap.2025.117657_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bph.15949","article-title":"Repurposing nitazoxanide as a novel anti-atherosclerotic drug based on mitochondrial uncoupling mechanisms","volume":"180","author":"Ma","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117657_bb0145","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.taap.2025.117657_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.taap.2025.117657_bb0155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04229-2020","article-title":"Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation","volume":"58","author":"Montani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2025.117657_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jchf.2023.03.010","article-title":"Role of oxygen starvation in right ventricular decompensation and failure in pulmonary arterial hypertension","volume":"12","author":"Okni\u0144ska","year":"2024","journal-title":"JACC Heart Failure."},{"key":"10.1016\/j.taap.2025.117657_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2025.117657_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCRESAHA.115.301130","article-title":"The metabolic theory of pulmonary arterial hypertension","volume":"115","author":"Paulin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2025.117657_bb0175","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1210\/clinem\/dgaa814","article-title":"Placental inositol reduced in gestational diabetes as glucose alters inositol transporters and IMPA1 enzyme expression","volume":"106","author":"Pillai","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.taap.2025.117657_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/rir-2025-0004","article-title":"Nitazoxanide alleviates CFA-induced rheumatoid arthritis in Wistar rats by modulating the STAT-3 and NF-\u03baB pathways","volume":"6","author":"Prajapati","year":"2025","journal-title":"Rheumatol. Immunol. Res."},{"issue":"3","key":"10.1016\/j.taap.2025.117657_bb0185","first-page":"413","article-title":"Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats","volume":"25","author":"Ruiz-Olmedo","year":"2017","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"10.1016\/j.taap.2025.117657_bb0190","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2025.117657_bb0195","doi-asserted-by":"crossref","first-page":"L428","DOI":"10.1152\/ajplung.00393.2018","article-title":"Inositol monophosphatase 1 as a novel interacting partner of RAGE in pulmonary hypertension","volume":"316","author":"Ruslan","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.taap.2025.117657_bb0200","article-title":"IMPA1 dependent regulation of phosphatidylinositol 4,5-bisphosphate and calcium signalling by lithium","volume":"7","author":"Saha","year":"2023","journal-title":"Life Sci. Alliance."},{"key":"10.1016\/j.taap.2025.117657_bb0205","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-14-0792","article-title":"Three-dimensional cell culture-based screening identifies the anthelmintic drug nitazoxanide as a candidate for treatment of colorectal cancer","volume":"14","author":"Senkowski","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2025.117657_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2025.117657_bb0215","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41598-022-06238-z","article-title":"Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","volume":"12","author":"Smolders","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117657_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bph.15016","article-title":"Current and future treatments of pulmonary arterial hypertension","volume":"178","author":"Sommer","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.taap.2025.117657_bb0225","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1039\/C6CC00975A","article-title":"Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics","volume":"52","author":"Suresh","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.taap.2025.117657_bb0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1164\/rccm.201108-1536PP","article-title":"Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension","volume":"185","author":"Tuder","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2025.117657_bb0235","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2025.117657_bb0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/09059180.00006511","article-title":"The role of the right ventricle in pulmonary arterial hypertension","volume":"20","author":"Vonk Noordegraaf","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.taap.2025.117657_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176492","article-title":"Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension","volume":"970","author":"Wang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.taap.2025.117657_bb0250","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400585RRR","article-title":"CircNAP1L4 regulates pulmonary artery smooth muscle cell proliferation via the NAP1L4-mediated super-enhancer-driven glycolysis gene hexokinase II (HK II) in pulmonary hypertension","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2025.117657_bb0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40659-023-00480-z","article-title":"The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension","volume":"56","author":"Wu","year":"2023","journal-title":"Biol. Res."},{"key":"10.1016\/j.taap.2025.117657_bb0260","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/bph.14182","article-title":"Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries","volume":"175","author":"Xiao","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117657_bb0270","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1096\/fj.04-2317fje","article-title":"Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension","volume":"18","author":"Xu","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2025.117657_bb0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","article-title":"Metabolism in pulmonary hypertension","volume":"83","author":"Xu","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.taap.2025.117657_bb0280","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/cam4.4970","article-title":"Inositol monophosphatase 1 (IMPA1) promotes triple- negative breast cancer progression through regulating mTOR pathway and EMT process","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.taap.2025.117657_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111075","article-title":"N6-methyladenosine (m6a) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability","volume":"133","author":"Yu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2025.117657_bb0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2017.10.037","article-title":"LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension","volume":"818","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117657_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajh\/hpy191","article-title":"3-Bromopyruvate attenuates experimental pulmonary hypertension via inhibition of glycolysis","volume":"32","author":"Zhang","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.taap.2025.117657_bb0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41420-023-01390-5","article-title":"JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov."}],"updated-by":[{"DOI":"10.1016\/j.taap.2026.117932","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000}},{"DOI":"10.1016\/j.taap.2026.117932","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:58:56Z","timestamp":1784746736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25004338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S0041008X25004338"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117657","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117657"}}